English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Tools annual

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Presents the access of premium content as premium feature

Premium Content

Global: Zendy Plus annual

Global: Zendy Free Plan

We aimed to determine the role of thyroid-stimulating hormone (TSH) of postmenopausal type 2 diabetes mellitus (T2DM) women with normal thyroid function in identifying ultrasound-diagnosed nonalcoholic fatty liver disease (NAFLD). The association between ultrasound-diagnosed NAFLD and biochemical parameters of 376 patients was analyzed among overall patients and in different age groups (≤60 years; 60–70 years; &gt;70 years). The receiver operating characteristic curve (ROC) was used to analyze the diagnostic ability of TSH for ultrasound-diagnosed NAFLD. The prevalence of ultrasound-diagnosed NAFLD in postmenopausal T2DM women was 44.1%. Multivariate logistic regression analysis showed that the levels of BMI (OR =  0 .843, 95%CI: 0.779–0.913), HbA1c (OR =  0 .836, 95%CI: 0.738–0.946), TG (OR =  0 .539, 95%CI: 0.408–0.712), ALT (OR =  0 .979, 95%CI: 0.962–0.995) were independent risk factors of NAFLD. BMI and TG were related to the NFALD risk of patients in the three age groups. HOMA-IR and HbA1c were independent risk factors of NAFLD among patients aged ≤60 years and 60–70 years, respectively. The TSH with the best diagnostic ability was among ≤60 years old patients (sensitivity = 0.486; specificity = 0.730). Higher BMI, abnormal glucose and lipid metabolism had a higher risk for developing NFALD, and TSH diagnosis is more meaningful in relatively young patients.

all life

Predictive value of thyroid-stimulating hormone in postmenopausal type 2 diabetes mellitus patients with normal thyroid function associated with ultrasound-diagnosed non-alcoholic fatty liver disease